Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Redfield

Showing results (291-300 of 336) with videos related to

Pageof 34
Sort By:
Clinical Transplantation|January 10, 2018
The impact of kidney donor profile index on delayed graft function and transplant outcomes: A single-center analysisTiffany J Zens, Juan S Danobeitia, Glen Leverson, et al.
Transplant Immunology|December 16, 2025
Rituximab-based antibody mediated rejection therapy modestly reduces Xenoreactive antibodies: Implications for pig-to-human xenotransplantationSzu-Tsen Yeh, Nicole A Marshall, Brent P Lehman, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 17, 2021
Cytomegalovirus antiviral stewardship in the COVID-19 Era: Increasing complexity of prophylaxis and treatment and potential mitigation strategiesMargaret R Jorgenson, Jillian L Descourouez, Cynthia Wong, et al.
The Journal of Infectious Diseases|February 1, 1997
Proteosomes, emulsomes, and cholera toxin B improve nasal immunogenicity of human immunodeficiency virus gp160 in mice: induction of serum, intestinal, vaginal, and lung IgA and IgGG H Lowell, R W Kaminski, T C VanCott, et al.
The Journal of Antimicrobial Chemotherapy|June 23, 2017
Monotherapy with either dolutegravir or raltegravir fails to durably suppress HIV viraemia in humanized miceAlonso Heredia, Said Hassounah, Sandra Medina-Moreno, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 28, 2014
Influence of transportation cost on long-term retention in clinic for HIV patients in rural HaitiLeonard A Sowah, Franck V Turenne, Ulrike K Buchwald, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2012
Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNasesFiorenza Cocchi, Anthony L DeVico, Wuyuan Lu, et al.
Kidney360|April 4, 2022
Oxidized-ATP Attenuates Kidney Allograft Rejection By Inhibiting T-Cell, B-Cell, and Macrophage ActivityXiang Ding, Nancy A Wilson, Robert R Redfield, et al.
Human Gene Therapy|December 1, 1994
Consequences of stable transduction and antigen-inducible expression of the human interleukin-7 gene on tetanus-toxoid-specific T cellsJ H Kim, S Ratto, K V Sitz, et al.
Antiviral Therapy|December 22, 2018
Disparate effects of cytotoxic chemotherapy on the antiviral activity of antiretroviral therapy: implications for treatments of HIV-infected cancer patientsSandra Medina-Moreno, Juan C Zapata, Mackenzie L Cottrell, et al.
Pageof 34

Showing results (291-300 of 336) with videos related to

Sort By:
Pageof 34
Clinical Transplantation|January 10, 2018
The impact of kidney donor profile index on delayed graft function and transplant outcomes: A single-center analysisTiffany J Zens, Juan S Danobeitia, Glen Leverson, et al.
Transplant Immunology|December 16, 2025
Rituximab-based antibody mediated rejection therapy modestly reduces Xenoreactive antibodies: Implications for pig-to-human xenotransplantationSzu-Tsen Yeh, Nicole A Marshall, Brent P Lehman, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 17, 2021
Cytomegalovirus antiviral stewardship in the COVID-19 Era: Increasing complexity of prophylaxis and treatment and potential mitigation strategiesMargaret R Jorgenson, Jillian L Descourouez, Cynthia Wong, et al.
The Journal of Infectious Diseases|February 1, 1997
Proteosomes, emulsomes, and cholera toxin B improve nasal immunogenicity of human immunodeficiency virus gp160 in mice: induction of serum, intestinal, vaginal, and lung IgA and IgGG H Lowell, R W Kaminski, T C VanCott, et al.
The Journal of Antimicrobial Chemotherapy|June 23, 2017
Monotherapy with either dolutegravir or raltegravir fails to durably suppress HIV viraemia in humanized miceAlonso Heredia, Said Hassounah, Sandra Medina-Moreno, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 28, 2014
Influence of transportation cost on long-term retention in clinic for HIV patients in rural HaitiLeonard A Sowah, Franck V Turenne, Ulrike K Buchwald, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2012
Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNasesFiorenza Cocchi, Anthony L DeVico, Wuyuan Lu, et al.
Kidney360|April 4, 2022
Oxidized-ATP Attenuates Kidney Allograft Rejection By Inhibiting T-Cell, B-Cell, and Macrophage ActivityXiang Ding, Nancy A Wilson, Robert R Redfield, et al.
Human Gene Therapy|December 1, 1994
Consequences of stable transduction and antigen-inducible expression of the human interleukin-7 gene on tetanus-toxoid-specific T cellsJ H Kim, S Ratto, K V Sitz, et al.
Antiviral Therapy|December 22, 2018
Disparate effects of cytotoxic chemotherapy on the antiviral activity of antiretroviral therapy: implications for treatments of HIV-infected cancer patientsSandra Medina-Moreno, Juan C Zapata, Mackenzie L Cottrell, et al.
Pageof 34